Author

G. Warsow

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Approach:benchmark study· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:variant calling· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

A. Dimitrakopoulou-Strauss· 1 shared A. Pintzas· 1 shared B. C. Jones· 1 shared B. Hutter· 1 shared D. Huebschmann· 1 shared D. T. W. Jones· 1 shared E. I. Vlachavas· 1 shared G. N. Zografos· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Dimitrakopoulou-Strauss

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer

E. I. Vlachavas, K. Voutetakis, V. Kosmidou, S. Tsikalakis, S. Roditis, K. Pateas, R. Kim, K. Pagel, S. Wolf, G. Warsow, A. Dimitrakopoulou-Strauss, G. N. Zografos, A. Pintzas, J. Betge, O. Papadodima, S. Wiemann

This study identifies molecular vulnerabilities in colorectal cancer by analyzing MSI and MSS tumors, revealing distinct signaling pathways and potential therapeutic targets.

bioRxiv · Apr 17, 2024Cancer Biology

Comprehensive analysis of mutational signatures in pediatric cancers

V. Thatikonda, S. M. A. Islam, B. C. Jones, S. N. Groebner, G. Warsow, B. Hutter, D. Huebschmann, S. Froehling, M. Blattner-Johnson, D. T. W. Jones, L. B. Alexandrov, S. M. Pfister, N. Jaeger

This study analyzes mutational signatures in pediatric cancers, finding fewer active signatures compared to adult cancers and linking specific signatures to TP53 mutations and chromothripsis.

bioRxiv · Sep 28, 2021Cancer Biology